A Study on Administration Choices of Vedolizumab and Outcomes for Adults With Inflammatory Bowel Disease (IBD) (VARIETY - CROATIA AND SLOVENIA)
Clinical trial NCT04885920 · COMPLETED
Trial details
- NCT number
- NCT04885920
- Sponsor
- Takeda
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-02-22
- Primary completion
- 2024-03-12
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.